Systemic Sclerosis (SSc)
77
49
49
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
1.3%
1 terminated out of 77 trials
80.0%
-6.5% vs benchmark
4%
3 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (77)
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PRO-203 in Healthy Volunteers and Participants With Systemic Sclerosis
TL1A Inhibition in Systemic Sclerosis-Related Skin Fibrosis and Immunological Alterations: A Proof-of-Concept In Vitro Study (FIBROSTOP)
US Zamto-cel Autoimmune Diseases
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders
A Study of BEN301 Injection in theTreatment of Autoimmune Diseases
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
CD19/BCMA UCAR-T for B Cell-Related Autoimmune Disease
Controlling Hyperactive Immunity With Long-lived Lymphocytes
Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases
Intralesional Injection of STS in Treatment of Calcinosis
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Study Investigating the Safety of Anti-CD19 CAR-T Cells Therapy Produced at Gustave Roussy for Adults With Severe and Refractory Systemic Autoimmune Rheumatic Diseases
Umbilical Cord Mesenchymal Stem Cells (UC-MSC) in the Treatment of Systemic Sclerosis
MTS109 in Patients With Refractory Autoimmune Diseases
Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases
Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
Systemic Sclerosis DIet for GastrointESTinal Symptoms
Hand ScleroDerma Lived Experience Scale in Individuals With Systemic Sclerosis